Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

8

Number of overlapping holdings

26.7%

% of MEDX's 30 holdings also in PJP

36.4%

% of PJP's 22 holdings also in MEDX

Overlap by Weight
Sector Drift (MEDX minus PJP)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in PJP
Overlap
ELI LILLY & CO 15.9% 6.2% 6.2%
AMGEN INC 6.0% 6.3% 6.0%
ABBVIE INC 7.1% 5.2% 5.2%
MERCK & CO. INC. 5.1% 5.9% 5.1%
JOHNSON & JOHNSON 4.4% 5.4% 4.4%

Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PJP
ELI LILLY & CO 9.7%
ASTRAZENECA PLC-SPONS ADR 5.7%
NOVARTIS AG-ADR 5.7%
BRISTOL-MYERS SQUIBB CO 4.3%
CRISPR THERAPEUTICS AG 3.4%
ALKERMES PLC 3.2%
GLAXOSMITHKLINE PLC-SPON ADR 3.0%
IONIS PHARMACEUTICALS, INC. 2.7%
ALNYLAM PHARMACEUTICALS INC 2.5%
INTELLIA THERAPEUTICS, INC. 2.1%
MEDX Underweight Relative to PJP
GERON CORP -6.4%
ABBOTT LABORATORIES -5.2%
UNITED THERAPEUTICS CORP -4.6%
CORCEPT THERAPEUTICS INC -4.4%
LIGAND PHARMACEUTICALS-CL B -4.3%
BIOSANTE PHARMACEUTICALS INC -3.8%
INNOVIVA, INC. -3.6%
PACIRA PHARMACEUTICALS INC -3.6%
SUPERNUS PHARMACEUTICALS INC -3.5%
PRESTIGE BRANDS HOLDINGS INC -3.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY